HealthVerity and Medeloop Announce Strategic Partnership to Enhance Real-World Evidence Insights with AI-Driven Analytics

PHILADELPHIA and MENLO PARK, Calif., June 5, 2025 /PRNewswire/ — HealthVerity, the leader in real-world data (RWD) technology and privacy-compliant data exchange and Medeloop, innovators in AI-powered healthcare analytics, announced today an exclusive partnership designed to simplify and dramatically accelerate how pharmaceutical and biotech organizations, governments, and medical or public health researchers use real-world data for actionable insights and evidence generation.

This powerful collaboration unites HealthVerity’s extensive, privacy-compliant data ecosystem with Medeloop’s cutting-edge AI Agent Analytics technology, enabling customers to uncover insights with unprecedented speed and transform vast, complex datasets into clear, actionable intelligence. Medeloop is a no-code analytics platform where a simple written research question is transformed into a full study, allowing users to rapidly generate insights without requiring programming expertise. Innovative researchers and analytics teams will benefit from unparalleled analytical power, accelerating the speed and impact of their research and decision-making processes.

Through this partnership, Medeloop customers across Academic Medical Centers and Health Systems now have access to over 200 million de-identified patient records from HealthVerity’s real-world data ecosystem, empowering them to ask their most complex research questions against research grade RWD at scale. Concurrently, HealthVerity pharmaceutical and biotech clients benefit from immediate integration of Medeloop’s cutting-edge analytics technology, allowing them to generate deeper, more precise insights tailored specifically to their critical healthcare and research needs.

“Our partnership with Medeloop represents a dramatic leap forward in real-world data analytics,” said Andrew Kress, CEO of HealthVerity. “Previously, generating insights from real-world data required extensive teams and months of effort. Now, with this partnership combining our access to large-scale real-world data and Medeloop’s leading-edge technology, we’re enabling researchers and healthcare professionals to directly pose complex questions and receive powerful insights within minutes in a fully transparent, monitored, and human-guided fashion, fundamentally changing the pace and accessibility of data-driven healthcare research.”

René Caissie, CEO of Medeloop, added: “With HealthVerity, we’re reshaping the future of healthcare analytics. By integrating the latest innovations in AI Agent Analytics with the richest real-world datasets available, we empower customers to rapidly achieve insights previously out of reach. This partnership accelerates scientific discovery, drives innovation, and ultimately helps save lives by enabling faster, more informed decisions that improve public health outcomes.”

Media Contacts:

HealthVerity
info@healthverity.com

Medeloop
John W. Ayers, Ph.D., M.A.
jayers@medeloop.ai 

About HealthVerity

HealthVerity is the leader in privacy-protected real-world data exchange, transforming how healthcare and life sciences organizations connect and analyze disparate patient data. By enabling access to the industry’s largest RWD ecosystem, HealthVerity supports critical applications in clinical development, commercial strategy, and regulatory decision-making.

About Medeloop

Medeloop offers advanced, AI-powered analytics platforms designed to simplify and accelerate healthcare research, enabling pharmaceutical companies, healthcare providers, and researchers to rapidly derive actionable insights from complex real-world data by simply asking a question.

View original content to download multimedia:https://www.prnewswire.com/news-releases/healthverity-and-medeloop-announce-strategic-partnership-to-enhance-real-world-evidence-insights-with-ai-driven-analytics-302474350.html

SOURCE HealthVerity, Inc.

Staff

Recent Posts

Vent Creativity Appoints Paul Abrams as Vice President of Sales to Lead Commercial Growth

NEW YORK--(BUSINESS WIRE)--Vent Creativity, a medical technology company advancing AI-enabled surgical planning, today announced the…

8 hours ago

AEON Clinic Announces Next Generation Medicine Congress 2026 Event: A Global Convergence on Human Longevity in Dubai

AEON Clinic Elevates Dubai to Global Hub for Longevity Science, A Definitive Four-Day Summit Defining…

8 hours ago

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

1 day ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

1 day ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

1 day ago

Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles

Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…

1 day ago